Claudia Martinelli

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Efficacy and safety of sacituzumab govitecan in patients with metastatic HR+/HER2- pleomorphic lobular breast cancer complicated by renal impairment.

Efficacy and safety of sacituzumab govitecan in patients with metastatic HR+/HER2- pleomorphic lobular breast cancer complicated by renal impairment.

Journal: Recenti progressi in medicina

Published: September 02, 2026

CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety.

CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety.

Journal: Clinical breast cancer

Published: April 22, 2026

The long road after breast cancer: survivorship issues and long-term treatment effects in young women.

The long road after breast cancer: survivorship issues and long-term treatment effects in young women.

Journal: Frontiers in oncology

Published: March 27, 2026

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal.

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal.

Journal: Cancer treatment reviews

Published: March 12, 2026

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Journal: JCO clinical cancer informatics

Published: March 06, 2026

Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives.

Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives.

Journal: Cancer treatment reviews

Published: August 21, 2025

Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2- Breast Cancer: A Systematic Review.

Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2- Breast Cancer: A Systematic Review.

Journal: Cancers

Published: July 08, 2025

Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study.

Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 24, 2025

CAR-T cell therapy for breast cancer: Current status and future perspective.

CAR-T cell therapy for breast cancer: Current status and future perspective.

Journal: Cancer treatment reviews

Published: October 29, 2024

The multidisciplinary management of HER2-positive breast cancer brain metastases: from new biological insights to future therapeutic options.

The multidisciplinary management of HER2-positive breast cancer brain metastases: from new biological insights to future therapeutic options.

Journal: Frontiers in oncology

Published: June 11, 2024

Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis.

Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis.

Journal: Frontiers in oncology

Published: December 28, 2023

Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion.

Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion.

Journal: Future oncology (London, England)

Published: August 22, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026